Unicycive Therapeutics, Inc.
UNCY
$5.00
-$0.02-0.40%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
8/6/2026
-
MarketBeat
8/1/2026
-
Tickeron - Stocks
7/30/2026
-
Tickeron - Stocks
7/30/2026
-
Tickeron - Stocks
7/29/2026
-
The Cerbat Gem
7/25/2026
-
Seeking Alpha - Healthcare
Unicycive Therapeutics (UNCY, $5.46) Stochastic Oscillator left the overbought zone on July 23, 2026
7/24/2026
-
Tickeron - Stocks
Unicycive Therapeutics (UNCY, $5.57) Stochastic Oscillator left the overbought zone on July 22, 2026
7/24/2026
-
Tickeron - Stocks
7/23/2026
-
MarketBeat
7/21/2026
-
Tickeron - Stocks
7/18/2026
-
Tickeron - Stocks
7/16/2026
-
Tickeron - Stocks
7/14/2026
-
TipRanks
7/13/2026
-
Globe Newswire
7/11/2026
-
Globe Newswire
7/9/2026
-
Business Wire
7/8/2026
-
Business Wire
7/8/2026
-
Business Wire
7/7/2026
-
GuruFocus
7/7/2026
-
Business Wire
7/7/2026
-
Tickeron - Stocks
7/7/2026
-
Globe Newswire
7/4/2026
-
Simply Wall St
7/4/2026
-
Tickeron - Stocks
7/4/2026
-
Tickeron - Stocks
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, March 30, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
(est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
650 351 4495
Address
1975 West El Camino Real
Suite 204
Mountain View, CA 94040
Suite 204
Mountain View, CA 94040
Country
Year Founded
Business Description
Sector
Unicycive Therapeutics, Inc., a clinical-stage biotechnology company, identifies, develops, and commercializes therapies for the treatment of kidney diseases in the United States. It develops...
more